全文获取类型
收费全文 | 6137篇 |
免费 | 616篇 |
国内免费 | 320篇 |
出版年
2024年 | 24篇 |
2023年 | 179篇 |
2022年 | 166篇 |
2021年 | 433篇 |
2020年 | 386篇 |
2019年 | 411篇 |
2018年 | 340篇 |
2017年 | 253篇 |
2016年 | 266篇 |
2015年 | 316篇 |
2014年 | 453篇 |
2013年 | 479篇 |
2012年 | 244篇 |
2011年 | 323篇 |
2010年 | 251篇 |
2009年 | 267篇 |
2008年 | 261篇 |
2007年 | 319篇 |
2006年 | 261篇 |
2005年 | 250篇 |
2004年 | 218篇 |
2003年 | 190篇 |
2002年 | 203篇 |
2001年 | 124篇 |
2000年 | 73篇 |
1999年 | 65篇 |
1998年 | 60篇 |
1997年 | 58篇 |
1996年 | 34篇 |
1995年 | 38篇 |
1994年 | 26篇 |
1993年 | 20篇 |
1992年 | 18篇 |
1991年 | 10篇 |
1990年 | 5篇 |
1989年 | 11篇 |
1988年 | 8篇 |
1987年 | 5篇 |
1986年 | 3篇 |
1985年 | 6篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1980年 | 1篇 |
1979年 | 4篇 |
1975年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有7073条查询结果,搜索用时 0 毫秒
991.
Lucilia sericata larvae are used in maggot debridement therapy, a traditional wound healing approach that has recently been approved for the treatment of chronic wounds. Maggot excretion products (MEP) contain many different proteases that promote disinfection, debridement and the acceleration of wound healing, e.g. by activating the host contact phase/intrinsic pathway of coagulation. In order to characterise relevant procoagulant proteases, we analysed MEP and identified a chymotrypsin-like serine protease with similarities to Jonah proteases from Drosophila melanogaster and a chymotrypsin from Lucilia cuprina. A recombinant form of the L. sericata Jonah chymotrypsin was produced in Escherichia coli. The activated enzyme (Jonahm) had a pH optimum of 8.0 and a temperature optimum of 37 °C, based on the cleavage of the chromogenic peptide s-7388 and casein. Jonahm reduced the clotting time of human plasma even in the absence of the endogenous protease kallikrein, factor XI or factor XII and digested the extracellular matrix proteins fibronectin, laminin and collagen IV, suggesting a potential mechanism of wound debridement. Based on these characteristics, the novel L. sericata chymotrypsin-like serine protease appears to be an ideal candidate for the development of topical drugs for wound healing applications. 相似文献
992.
Promoter optimisation of lentiviral vectors for efficient insulin gene expression in canine mesenchymal stromal cells: potential surrogate beta cells 下载免费PDF全文
993.
994.
Radioiodine therapy is an effective and safe treatment of hyperthyroidism due to Graves’ disease, toxic adenoma, toxic multinodular goiter. We compared the outcomes of a traditional calculation method based on an analytical fit of the uptake curve and subsequent dose calculation with the MIRD approach, and an alternative computation approach based on a formulation implemented in a public-access website, searching for the best timing of radioiodine uptake measurements in pre-therapeutic dosimetry. We report about sixty-nine hyperthyroid patients that were treated after performing a pre-therapeutic dosimetry calculated by fitting a six-point uptake curve (3–168 h). In order to evaluate the results of the radioiodine treatment, patients were followed up to sixty-four months after treatment (mean 47.4 ± 16.9). Patient dosimetry was then retrospectively recalculated with the two above-mentioned methods. Several time schedules for uptake measurements were considered, with different timings and total number of points. Early time schedules, sampling uptake up to 48 h, do not allow to set-up an accurate treatment plan, while schedules including the measurement at one week give significantly better results. The analytical fit procedure applied to the three-point time schedule 3(6)–24–168 h gave results significantly more accurate than the website approach exploiting either the same schedule, or the single measurement at 168 h. Consequently, the best strategy among the ones considered is to sample the uptake at 3(6)–24–168 h, and carry out an analytical fit of the curve, while extra measurements at 48 and 72 h lead only marginal improvements in the accuracy of therapeutic activity determination. 相似文献
995.
996.
Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third‐Line Treatment of Helicobacter pylori Infection: Two Pilot Studies 下载免费PDF全文
997.
998.
999.
1000.
Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction 总被引:4,自引:0,他引:4
Sun L Cui M Wang Z Feng X Mao J Chen P Kangtao M Chen F Zhou C 《Biochemical and biophysical research communications》2007,357(3):779-784
We used human angiopoietin-1 (hAng1)-modified mesenchymal stem cells (MSCs) to treat acute myocardial infarction (AMI) in rats. The hAng1 gene was transfected into cultured rat MSCs using an adenoviral vector. Five million hAng-transfected MSCs (MSC(Ang1)) or green fluorescent protein transfected MSCs (MSC(GFP)) or PBS only (PBS group) were injected intramyocardially into the inbred Lewis rat hearts immediately after myocardial infarction. MSC(Ang1) survived in the infarcted myocardium, and expressed hAng1 at both mRNA and protein levels. The vascular density was higher in the MSC(Ang1) and MSC(GFP) groups than in the PBS group. The measurements of infarcted ventricular wall thickness, infarction area, and left ventricular diameter indicated that heart remodeling was inhibited and heart function was improved in both the MSC(Ang1) and MSC(GFP) groups. However, in contrast to the MSC(GFP) group, the MSC(Ang1) group showed enhanced angiogenesis and arteriogenesis (by 11-35%), infarction area was reduced by 30% and the left ventricular wall was 46% thicker (P<0.05). The results indicated that hAng1-modified MSCs improved heart function, followed by angiogenic effects in salvaging ischemic myocardium and reduced cardiac remodeling. 相似文献